114 related articles for article (PubMed ID: 24047268)
1. Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?
Schirrmacher R; Bernard-Gauthier V; Reader A; Soucy JP; Schirrmacher E; Wängler B; Wängler C
Future Med Chem; 2013 Sep; 5(14):1621-34. PubMed ID: 24047268
[TBL] [Abstract][Full Text] [Related]
2. Diphenhydramine as a selective probe to study H
Auvity S; Chapy H; Goutal S; Caillé F; Hosten B; Smirnova M; Declèves X; Tournier N; Cisternino S
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2185-2195. PubMed ID: 27488910
[TBL] [Abstract][Full Text] [Related]
3. [Imaging blood-brain barrier function by using positron emission tomography to evaluate drug penetration into the brain].
Takano H; Suhara T
Brain Nerve; 2013 Feb; 65(2):137-43. PubMed ID: 23399671
[TBL] [Abstract][Full Text] [Related]
4. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood-brain barrier.
Lindberg A; Chassé M; Varlow C; Pees A; Vasdev N
J Labelled Comp Radiopharm; 2023 Jul; 66(9):205-221. PubMed ID: 36815704
[TBL] [Abstract][Full Text] [Related]
5. Brain Vascular Imaging Techniques.
Laviña B
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28042833
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
7. PET radiotracers: crossing the blood-brain barrier and surviving metabolism.
Pike VW
Trends Pharmacol Sci; 2009 Aug; 30(8):431-40. PubMed ID: 19616318
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging.
Syvänen S; Hammarlund-Udenaes M; Loryan I
Handb Exp Pharmacol; 2022; 273():223-244. PubMed ID: 33387067
[TBL] [Abstract][Full Text] [Related]
9. Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery.
Tavares AA; Lewsey J; Dewar D; Pimlott SL
Nucl Med Biol; 2012 Jan; 39(1):127-35. PubMed ID: 21958855
[TBL] [Abstract][Full Text] [Related]
10. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
[TBL] [Abstract][Full Text] [Related]
11. Small-animal positron emission tomography as a tool for neuropharmacology.
Lancelot S; Zimmer L
Trends Pharmacol Sci; 2010 Sep; 31(9):411-7. PubMed ID: 20599282
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Fluorescent Nanoparticles to the Brain.
Shimoni O; Shi B; Adlard PA; Bush AI
J Mol Neurosci; 2016 Nov; 60(3):405-409. PubMed ID: 27660216
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.
Pike VW
Curr Med Chem; 2016; 23(18):1818-69. PubMed ID: 27087244
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier delivery.
Pardridge WM
Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.
Josserand V; Pélerin H; de Bruin B; Jego B; Kuhnast B; Hinnen F; Ducongé F; Boisgard R; Beuvon F; Chassoux F; Daumas-Duport C; Ezan E; Dollé F; Mabondzo A; Tavitian B
J Pharmacol Exp Ther; 2006 Jan; 316(1):79-86. PubMed ID: 16210395
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Mansi R; Wang X; Forrer F; Kneifel S; Tamma ML; Waser B; Cescato R; Reubi JC; Maecke HR
Clin Cancer Res; 2009 Aug; 15(16):5240-9. PubMed ID: 19671861
[TBL] [Abstract][Full Text] [Related]
18. The use and importance of liposomes in positron emission tomography.
Silindir M; Özer AY; Erdoğan S
Drug Deliv; 2012 Jan; 19(1):68-80. PubMed ID: 22211758
[TBL] [Abstract][Full Text] [Related]
19. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.
Sasongko L; Link JM; Muzi M; Mankoff DA; Yang X; Collier AC; Shoner SC; Unadkat JD
Clin Pharmacol Ther; 2005 Jun; 77(6):503-14. PubMed ID: 15961982
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of cerebral glucose metabolic rates after blood-brain barrier disruption induced by focused ultrasound using FDG-MicroPET.
Yang FY; Chang WY; Chen JC; Lee LC; Hung YS
Neuroimage; 2014 Apr; 90():93-8. PubMed ID: 24368263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
